Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCOMI: Coenzyme Q10 in Acute STEMI
NCT06661018Completed
- Sponsor
- Diponegoro University
- Start
- Jan 2024
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Coenzyme Q10 with Placebo (2 arms). Primary endpoint: Global Longitudinal Strain at 8 weeks. Started Jan 2024; status: completed.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06661018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06661018.